Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells
- 30 November 1998
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 34 (12), 1927-1934
- https://doi.org/10.1016/s0959-8049(98)00198-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in ratsCarcinogenesis: Integrative Cancer Research, 1996
- Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinasesScience, 1995
- The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cellsLeukemia Research, 1994
- Inhibition of Topoisomerase IIα Activity in CHO K1 Cells by 2-[(Aminopropyl)Amino]Ethanethiol (WR-1065)Radiation Research, 1994
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994
- Genistein, a Tyrosine Kinase Inhibitor, Blocks the Cell Cycle Progression but not Ca2+ Influx Induced by BAY K8644 in FRTL-5 CellsBiochemical and Biophysical Research Communications, 1993
- [30] Use and specificity of genistein as inhibitor of protein-tyrosine kinasesMethods in Enzymology, 1991
- Effect of genistein on topoisomerase activity and on the growth of [VAL 12]Ha-ras-transformed NIH 3T3 cellsBiochemical and Biophysical Research Communications, 1988
- Phytoestrogen Interaction with Estrogen Receptors in Human Breast Cancer Cells*Endocrinology, 1978
- Estrogenic Activity of Isoflavone Derivatives Extracted and Prepared from Soybean Oil MealScience, 1953